Get Real Time Here
| Open1.130 | Close1.050 |
| Vol / Avg.803.440K / 330.315K | Mkt Cap86.851M |
| Day Range1.010 - 1.170 | 52 Wk Range1.120 - 14.400 |
NGM Biopharmaceuticals Stock (NASDAQ:NGM), Quotes and News Summary
NGM Biopharmaceuticals Stock (NASDAQ: NGM) stock price, news, charts, stock research, profile.
| Open1.130 | Close1.050 |
| Vol / Avg.803.440K / 330.315K | Mkt Cap86.851M |
| Day Range1.010 - 1.170 | 52 Wk Range1.120 - 14.400 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.500 | -0.460 | 0.0400 | ||||
| REV | 3.300M | 1.423M | -1.877M |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-05-03 | Citigroup | Samantha Semenkow | Initiates Coverage On | Buy | Announces | - | 6.00 |
| 2023-03-30 | B. Riley Securities | Mayank Mamtani | Maintains | Buy | Lowers | 8.00 | 7.00 |
| 2022-11-04 | Raymond James | Steven Seedhouse | Maintains | Outperform | Raises | 4.00 | 6.00 |
| 2022-10-18 | Cowen & Co. | Ritu Baral | Maintains | Outperform | Lowers | 32.00 | 9.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| NGM | NGM Biopharmaceuticals | -6.25% | 86.9M |
| SCYX | SCYNEXIS | -2.65% | 123.1M |
| OCUP | Ocuphire Pharma | -0.51% | 82.2M |
| RANI | Rani Therapeutics Hldgs | -6.08% | 71M |
| LBPH | Longboard Pharmaceuticals | 0.72% | 128.9M |
How do I buy NGM Biopharmaceuticals (NGM) stock?
You can purchase shares of NGM Biopharmaceuticals (NASDAQ: NGM) through any online brokerage.
Who are NGM Biopharmaceuticals's (NGM) competitors?
Other companies in NGM Biopharmaceuticals’s space includes: SCYNEXIS (NASDAQ:SCYX), Ocuphire Pharma (NASDAQ:OCUP), Rani Therapeutics Hldgs (NASDAQ:RANI), Longboard Pharmaceuticals (NASDAQ:LBPH) and Aquestive Therapeutics (NASDAQ:AQST).
What is the target price for NGM Biopharmaceuticals (NGM) stock?
The latest price target for NGM Biopharmaceuticals (NASDAQ: NGM) was reported by Citigroup on Wednesday, May 3, 2023. The analyst firm set a price target for 6.00 expecting NGM to rise to within 12 months (a possible 471.43% upside). 9 analyst firms have reported ratings in the last year.
Current Stock Price for NGM Biopharmaceuticals (NGM)?
The stock price for NGM Biopharmaceuticals (NASDAQ: NGM) is $1.05 last updated September 22, 2023 at 8:00 PM UTC.
Does NGM Biopharmaceuticals (NGM) pay a dividend?
There is no dividend information for NGM Biopharmaceuticals.
When is NGM Biopharmaceuticals (NASDAQ:NGM) reporting earnings?
NGM Biopharmaceuticals’s Q3 earnings are confirmed for Thursday, November 2, 2023.
Is NGM Biopharmaceuticals (NGM) going to split?
There is no upcoming split for NGM Biopharmaceuticals.
What sector and industry does NGM Biopharmaceuticals (NGM) operate in?
NGM Biopharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
NGM Biopharmaceuticals Stock (NASDAQ:NGM), Quotes and News Summary
NGM Biopharmaceuticals Stock (NASDAQ: NGM) stock price, news, charts, stock research, profile.
| Open1.130 | Close1.050 |
| Vol / Avg.803.440K / 330.315K | Mkt Cap86.851M |
| Day Range1.010 - 1.170 | 52 Wk Range1.120 - 14.400 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.500 | -0.460 | 0.0400 | ||||
| REV | 3.300M | 1.423M | -1.877M |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-05-03 | Citigroup | Samantha Semenkow | Initiates Coverage On | Buy | Announces | - | 6.00 |
| 2023-03-30 | B. Riley Securities | Mayank Mamtani | Maintains | Buy | Lowers | 8.00 | 7.00 |
| 2022-11-04 | Raymond James | Steven Seedhouse | Maintains | Outperform | Raises | 4.00 | 6.00 |
| 2022-10-18 | Cowen & Co. | Ritu Baral | Maintains | Outperform | Lowers | 32.00 | 9.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| NGM | NGM Biopharmaceuticals | -6.25% | 86.9M |
| SCYX | SCYNEXIS | -2.65% | 123.1M |
| OCUP | Ocuphire Pharma | -0.51% | 82.2M |
| RANI | Rani Therapeutics Hldgs | -6.08% | 71M |
| LBPH | Longboard Pharmaceuticals | 0.72% | 128.9M |
How do I buy NGM Biopharmaceuticals (NGM) stock?
You can purchase shares of NGM Biopharmaceuticals (NASDAQ: NGM) through any online brokerage.
Who are NGM Biopharmaceuticals's (NGM) competitors?
Other companies in NGM Biopharmaceuticals’s space includes: SCYNEXIS (NASDAQ:SCYX), Ocuphire Pharma (NASDAQ:OCUP), Rani Therapeutics Hldgs (NASDAQ:RANI), Longboard Pharmaceuticals (NASDAQ:LBPH) and Aquestive Therapeutics (NASDAQ:AQST).
What is the target price for NGM Biopharmaceuticals (NGM) stock?
The latest price target for NGM Biopharmaceuticals (NASDAQ: NGM) was reported by Citigroup on Wednesday, May 3, 2023. The analyst firm set a price target for 6.00 expecting NGM to rise to within 12 months (a possible 471.43% upside). 9 analyst firms have reported ratings in the last year.
Current Stock Price for NGM Biopharmaceuticals (NGM)?
The stock price for NGM Biopharmaceuticals (NASDAQ: NGM) is $1.05 last updated September 22, 2023 at 8:00 PM UTC.
Does NGM Biopharmaceuticals (NGM) pay a dividend?
There is no dividend information for NGM Biopharmaceuticals.
When is NGM Biopharmaceuticals (NASDAQ:NGM) reporting earnings?
NGM Biopharmaceuticals’s Q3 earnings are confirmed for Thursday, November 2, 2023.
Is NGM Biopharmaceuticals (NGM) going to split?
There is no upcoming split for NGM Biopharmaceuticals.
What sector and industry does NGM Biopharmaceuticals (NGM) operate in?
NGM Biopharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
NGM Biopharmaceuticals Stock (NASDAQ:NGM), Quotes and News Summary
NGM Biopharmaceuticals Stock (NASDAQ: NGM) stock price, news, charts, stock research, profile.
| Open1.130 | Close1.050 |
| Vol / Avg.803.440K / 330.315K | Mkt Cap86.851M |
| Day Range1.010 - 1.170 | 52 Wk Range1.120 - 14.400 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.500 | -0.460 | 0.0400 | ||||
| REV | 3.300M | 1.423M | -1.877M |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-05-03 | Citigroup | Samantha Semenkow | Initiates Coverage On | Buy | Announces | - | 6.00 |
| 2023-03-30 | B. Riley Securities | Mayank Mamtani | Maintains | Buy | Lowers | 8.00 | 7.00 |
| 2022-11-04 | Raymond James | Steven Seedhouse | Maintains | Outperform | Raises | 4.00 | 6.00 |
| 2022-10-18 | Cowen & Co. | Ritu Baral | Maintains | Outperform | Lowers | 32.00 | 9.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| NGM | NGM Biopharmaceuticals | -6.25% | 86.9M |
| SCYX | SCYNEXIS | -2.65% | 123.1M |
| OCUP | Ocuphire Pharma | -0.51% | 82.2M |
| RANI | Rani Therapeutics Hldgs | -6.08% | 71M |
| LBPH | Longboard Pharmaceuticals | 0.72% | 128.9M |
How do I buy NGM Biopharmaceuticals (NGM) stock?
You can purchase shares of NGM Biopharmaceuticals (NASDAQ: NGM) through any online brokerage.
Who are NGM Biopharmaceuticals's (NGM) competitors?
Other companies in NGM Biopharmaceuticals’s space includes: SCYNEXIS (NASDAQ:SCYX), Ocuphire Pharma (NASDAQ:OCUP), Rani Therapeutics Hldgs (NASDAQ:RANI), Longboard Pharmaceuticals (NASDAQ:LBPH) and Aquestive Therapeutics (NASDAQ:AQST).
What is the target price for NGM Biopharmaceuticals (NGM) stock?
The latest price target for NGM Biopharmaceuticals (NASDAQ: NGM) was reported by Citigroup on Wednesday, May 3, 2023. The analyst firm set a price target for 6.00 expecting NGM to rise to within 12 months (a possible 471.43% upside). 9 analyst firms have reported ratings in the last year.
Current Stock Price for NGM Biopharmaceuticals (NGM)?
The stock price for NGM Biopharmaceuticals (NASDAQ: NGM) is $1.05 last updated September 22, 2023 at 8:00 PM UTC.
Does NGM Biopharmaceuticals (NGM) pay a dividend?
There is no dividend information for NGM Biopharmaceuticals.
When is NGM Biopharmaceuticals (NASDAQ:NGM) reporting earnings?
NGM Biopharmaceuticals’s Q3 earnings are confirmed for Thursday, November 2, 2023.
Is NGM Biopharmaceuticals (NGM) going to split?
There is no upcoming split for NGM Biopharmaceuticals.
What sector and industry does NGM Biopharmaceuticals (NGM) operate in?
NGM Biopharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
NGM Biopharmaceuticals Stock (NASDAQ:NGM), Quotes and News Summary
NGM Biopharmaceuticals Stock (NASDAQ: NGM) stock price, news, charts, stock research, profile.
| Open1.130 | Close1.050 |
| Vol / Avg.803.440K / 330.315K | Mkt Cap86.851M |
| Day Range1.010 - 1.170 | 52 Wk Range1.120 - 14.400 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.500 | -0.460 | 0.0400 | ||||
| REV | 3.300M | 1.423M | -1.877M |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-05-03 | Citigroup | Samantha Semenkow | Initiates Coverage On | Buy | Announces | - | 6.00 |
| 2023-03-30 | B. Riley Securities | Mayank Mamtani | Maintains | Buy | Lowers | 8.00 | 7.00 |
| 2022-11-04 | Raymond James | Steven Seedhouse | Maintains | Outperform | Raises | 4.00 | 6.00 |
| 2022-10-18 | Cowen & Co. | Ritu Baral | Maintains | Outperform | Lowers | 32.00 | 9.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| NGM | NGM Biopharmaceuticals | -6.25% | 86.9M |
| SCYX | SCYNEXIS | -2.65% | 123.1M |
| OCUP | Ocuphire Pharma | -0.51% | 82.2M |
| RANI | Rani Therapeutics Hldgs | -6.08% | 71M |
| LBPH | Longboard Pharmaceuticals | 0.72% | 128.9M |
How do I buy NGM Biopharmaceuticals (NGM) stock?
You can purchase shares of NGM Biopharmaceuticals (NASDAQ: NGM) through any online brokerage.
Who are NGM Biopharmaceuticals's (NGM) competitors?
Other companies in NGM Biopharmaceuticals’s space includes: SCYNEXIS (NASDAQ:SCYX), Ocuphire Pharma (NASDAQ:OCUP), Rani Therapeutics Hldgs (NASDAQ:RANI), Longboard Pharmaceuticals (NASDAQ:LBPH) and Aquestive Therapeutics (NASDAQ:AQST).
What is the target price for NGM Biopharmaceuticals (NGM) stock?
The latest price target for NGM Biopharmaceuticals (NASDAQ: NGM) was reported by Citigroup on Wednesday, May 3, 2023. The analyst firm set a price target for 6.00 expecting NGM to rise to within 12 months (a possible 471.43% upside). 9 analyst firms have reported ratings in the last year.
Current Stock Price for NGM Biopharmaceuticals (NGM)?
The stock price for NGM Biopharmaceuticals (NASDAQ: NGM) is $1.05 last updated September 22, 2023 at 8:00 PM UTC.
Does NGM Biopharmaceuticals (NGM) pay a dividend?
There is no dividend information for NGM Biopharmaceuticals.
When is NGM Biopharmaceuticals (NASDAQ:NGM) reporting earnings?
NGM Biopharmaceuticals’s Q3 earnings are confirmed for Thursday, November 2, 2023.
Is NGM Biopharmaceuticals (NGM) going to split?
There is no upcoming split for NGM Biopharmaceuticals.
What sector and industry does NGM Biopharmaceuticals (NGM) operate in?
NGM Biopharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
NGM Biopharmaceuticals Stock (NASDAQ:NGM), Quotes and News Summary
NGM Biopharmaceuticals Stock (NASDAQ: NGM) stock price, news, charts, stock research, profile.
| Open1.130 | Close1.050 |
| Vol / Avg.803.440K / 330.315K | Mkt Cap86.851M |
| Day Range1.010 - 1.170 | 52 Wk Range1.120 - 14.400 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.500 | -0.460 | 0.0400 | ||||
| REV | 3.300M | 1.423M | -1.877M |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-05-03 | Citigroup | Samantha Semenkow | Initiates Coverage On | Buy | Announces | - | 6.00 |
| 2023-03-30 | B. Riley Securities | Mayank Mamtani | Maintains | Buy | Lowers | 8.00 | 7.00 |
| 2022-11-04 | Raymond James | Steven Seedhouse | Maintains | Outperform | Raises | 4.00 | 6.00 |
| 2022-10-18 | Cowen & Co. | Ritu Baral | Maintains | Outperform | Lowers | 32.00 | 9.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| NGM | NGM Biopharmaceuticals | -6.25% | 86.9M |
| SCYX | SCYNEXIS | -2.65% | 123.1M |
| OCUP | Ocuphire Pharma | -0.51% | 82.2M |
| RANI | Rani Therapeutics Hldgs | -6.08% | 71M |
| LBPH | Longboard Pharmaceuticals | 0.72% | 128.9M |
How do I buy NGM Biopharmaceuticals (NGM) stock?
You can purchase shares of NGM Biopharmaceuticals (NASDAQ: NGM) through any online brokerage.
Who are NGM Biopharmaceuticals's (NGM) competitors?
Other companies in NGM Biopharmaceuticals’s space includes: SCYNEXIS (NASDAQ:SCYX), Ocuphire Pharma (NASDAQ:OCUP), Rani Therapeutics Hldgs (NASDAQ:RANI), Longboard Pharmaceuticals (NASDAQ:LBPH) and Aquestive Therapeutics (NASDAQ:AQST).
What is the target price for NGM Biopharmaceuticals (NGM) stock?
The latest price target for NGM Biopharmaceuticals (NASDAQ: NGM) was reported by Citigroup on Wednesday, May 3, 2023. The analyst firm set a price target for 6.00 expecting NGM to rise to within 12 months (a possible 471.43% upside). 9 analyst firms have reported ratings in the last year.
Current Stock Price for NGM Biopharmaceuticals (NGM)?
The stock price for NGM Biopharmaceuticals (NASDAQ: NGM) is $1.05 last updated September 22, 2023 at 8:00 PM UTC.
Does NGM Biopharmaceuticals (NGM) pay a dividend?
There is no dividend information for NGM Biopharmaceuticals.
When is NGM Biopharmaceuticals (NASDAQ:NGM) reporting earnings?
NGM Biopharmaceuticals’s Q3 earnings are confirmed for Thursday, November 2, 2023.
Is NGM Biopharmaceuticals (NGM) going to split?
There is no upcoming split for NGM Biopharmaceuticals.
What sector and industry does NGM Biopharmaceuticals (NGM) operate in?
NGM Biopharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
NGM Biopharmaceuticals Stock (NASDAQ:NGM), Quotes and News Summary
NGM Biopharmaceuticals Stock (NASDAQ: NGM) stock price, news, charts, stock research, profile.
| Open1.130 | Close1.050 |
| Vol / Avg.803.440K / 330.315K | Mkt Cap86.851M |
| Day Range1.010 - 1.170 | 52 Wk Range1.120 - 14.400 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.500 | -0.460 | 0.0400 | ||||
| REV | 3.300M | 1.423M | -1.877M |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-05-03 | Citigroup | Samantha Semenkow | Initiates Coverage On | Buy | Announces | - | 6.00 |
| 2023-03-30 | B. Riley Securities | Mayank Mamtani | Maintains | Buy | Lowers | 8.00 | 7.00 |
| 2022-11-04 | Raymond James | Steven Seedhouse | Maintains | Outperform | Raises | 4.00 | 6.00 |
| 2022-10-18 | Cowen & Co. | Ritu Baral | Maintains | Outperform | Lowers | 32.00 | 9.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| NGM | NGM Biopharmaceuticals | -6.25% | 86.9M |
| SCYX | SCYNEXIS | -2.65% | 123.1M |
| OCUP | Ocuphire Pharma | -0.51% | 82.2M |
| RANI | Rani Therapeutics Hldgs | -6.08% | 71M |
| LBPH | Longboard Pharmaceuticals | 0.72% | 128.9M |
How do I buy NGM Biopharmaceuticals (NGM) stock?
You can purchase shares of NGM Biopharmaceuticals (NASDAQ: NGM) through any online brokerage.
Who are NGM Biopharmaceuticals's (NGM) competitors?
Other companies in NGM Biopharmaceuticals’s space includes: SCYNEXIS (NASDAQ:SCYX), Ocuphire Pharma (NASDAQ:OCUP), Rani Therapeutics Hldgs (NASDAQ:RANI), Longboard Pharmaceuticals (NASDAQ:LBPH) and Aquestive Therapeutics (NASDAQ:AQST).
What is the target price for NGM Biopharmaceuticals (NGM) stock?
The latest price target for NGM Biopharmaceuticals (NASDAQ: NGM) was reported by Citigroup on Wednesday, May 3, 2023. The analyst firm set a price target for 6.00 expecting NGM to rise to within 12 months (a possible 471.43% upside). 9 analyst firms have reported ratings in the last year.
Current Stock Price for NGM Biopharmaceuticals (NGM)?
The stock price for NGM Biopharmaceuticals (NASDAQ: NGM) is $1.05 last updated September 22, 2023 at 8:00 PM UTC.
Does NGM Biopharmaceuticals (NGM) pay a dividend?
There is no dividend information for NGM Biopharmaceuticals.
When is NGM Biopharmaceuticals (NASDAQ:NGM) reporting earnings?
NGM Biopharmaceuticals’s Q3 earnings are confirmed for Thursday, November 2, 2023.
Is NGM Biopharmaceuticals (NGM) going to split?
There is no upcoming split for NGM Biopharmaceuticals.
What sector and industry does NGM Biopharmaceuticals (NGM) operate in?
NGM Biopharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
NGM Biopharmaceuticals Stock (NASDAQ:NGM), Quotes and News Summary
NGM Biopharmaceuticals Stock (NASDAQ: NGM) stock price, news, charts, stock research, profile.
| Open1.130 | Close1.050 |
| Vol / Avg.803.440K / 330.315K | Mkt Cap86.851M |
| Day Range1.010 - 1.170 | 52 Wk Range1.120 - 14.400 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.500 | -0.460 | 0.0400 | ||||
| REV | 3.300M | 1.423M | -1.877M |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-05-03 | Citigroup | Samantha Semenkow | Initiates Coverage On | Buy | Announces | - | 6.00 |
| 2023-03-30 | B. Riley Securities | Mayank Mamtani | Maintains | Buy | Lowers | 8.00 | 7.00 |
| 2022-11-04 | Raymond James | Steven Seedhouse | Maintains | Outperform | Raises | 4.00 | 6.00 |
| 2022-10-18 | Cowen & Co. | Ritu Baral | Maintains | Outperform | Lowers | 32.00 | 9.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| NGM | NGM Biopharmaceuticals | -6.25% | 86.9M |
| SCYX | SCYNEXIS | -2.65% | 123.1M |
| OCUP | Ocuphire Pharma | -0.51% | 82.2M |
| RANI | Rani Therapeutics Hldgs | -6.08% | 71M |
| LBPH | Longboard Pharmaceuticals | 0.72% | 128.9M |
How do I buy NGM Biopharmaceuticals (NGM) stock?
You can purchase shares of NGM Biopharmaceuticals (NASDAQ: NGM) through any online brokerage.
Who are NGM Biopharmaceuticals's (NGM) competitors?
Other companies in NGM Biopharmaceuticals’s space includes: SCYNEXIS (NASDAQ:SCYX), Ocuphire Pharma (NASDAQ:OCUP), Rani Therapeutics Hldgs (NASDAQ:RANI), Longboard Pharmaceuticals (NASDAQ:LBPH) and Aquestive Therapeutics (NASDAQ:AQST).
What is the target price for NGM Biopharmaceuticals (NGM) stock?
The latest price target for NGM Biopharmaceuticals (NASDAQ: NGM) was reported by Citigroup on Wednesday, May 3, 2023. The analyst firm set a price target for 6.00 expecting NGM to rise to within 12 months (a possible 471.43% upside). 9 analyst firms have reported ratings in the last year.
Current Stock Price for NGM Biopharmaceuticals (NGM)?
The stock price for NGM Biopharmaceuticals (NASDAQ: NGM) is $1.05 last updated September 22, 2023 at 8:00 PM UTC.
Does NGM Biopharmaceuticals (NGM) pay a dividend?
There is no dividend information for NGM Biopharmaceuticals.
When is NGM Biopharmaceuticals (NASDAQ:NGM) reporting earnings?
NGM Biopharmaceuticals’s Q3 earnings are confirmed for Thursday, November 2, 2023.
Is NGM Biopharmaceuticals (NGM) going to split?
There is no upcoming split for NGM Biopharmaceuticals.
What sector and industry does NGM Biopharmaceuticals (NGM) operate in?
NGM Biopharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
NGM Biopharmaceuticals Stock (NASDAQ:NGM), Quotes and News Summary
NGM Biopharmaceuticals Stock (NASDAQ: NGM) stock price, news, charts, stock research, profile.
| Open1.130 | Close1.050 |
| Vol / Avg.803.440K / 330.315K | Mkt Cap86.851M |
| Day Range1.010 - 1.170 | 52 Wk Range1.120 - 14.400 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.500 | -0.460 | 0.0400 | ||||
| REV | 3.300M | 1.423M | -1.877M |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-05-03 | Citigroup | Samantha Semenkow | Initiates Coverage On | Buy | Announces | - | 6.00 |
| 2023-03-30 | B. Riley Securities | Mayank Mamtani | Maintains | Buy | Lowers | 8.00 | 7.00 |
| 2022-11-04 | Raymond James | Steven Seedhouse | Maintains | Outperform | Raises | 4.00 | 6.00 |
| 2022-10-18 | Cowen & Co. | Ritu Baral | Maintains | Outperform | Lowers | 32.00 | 9.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| NGM | NGM Biopharmaceuticals | -6.25% | 86.9M |
| SCYX | SCYNEXIS | -2.65% | 123.1M |
| OCUP | Ocuphire Pharma | -0.51% | 82.2M |
| RANI | Rani Therapeutics Hldgs | -6.08% | 71M |
| LBPH | Longboard Pharmaceuticals | 0.72% | 128.9M |
How do I buy NGM Biopharmaceuticals (NGM) stock?
You can purchase shares of NGM Biopharmaceuticals (NASDAQ: NGM) through any online brokerage.
Who are NGM Biopharmaceuticals's (NGM) competitors?
Other companies in NGM Biopharmaceuticals’s space includes: SCYNEXIS (NASDAQ:SCYX), Ocuphire Pharma (NASDAQ:OCUP), Rani Therapeutics Hldgs (NASDAQ:RANI), Longboard Pharmaceuticals (NASDAQ:LBPH) and Aquestive Therapeutics (NASDAQ:AQST).
What is the target price for NGM Biopharmaceuticals (NGM) stock?
The latest price target for NGM Biopharmaceuticals (NASDAQ: NGM) was reported by Citigroup on Wednesday, May 3, 2023. The analyst firm set a price target for 6.00 expecting NGM to rise to within 12 months (a possible 471.43% upside). 9 analyst firms have reported ratings in the last year.
Current Stock Price for NGM Biopharmaceuticals (NGM)?
The stock price for NGM Biopharmaceuticals (NASDAQ: NGM) is $1.05 last updated September 22, 2023 at 8:00 PM UTC.
Does NGM Biopharmaceuticals (NGM) pay a dividend?
There is no dividend information for NGM Biopharmaceuticals.
When is NGM Biopharmaceuticals (NASDAQ:NGM) reporting earnings?
NGM Biopharmaceuticals’s Q3 earnings are confirmed for Thursday, November 2, 2023.
Is NGM Biopharmaceuticals (NGM) going to split?
There is no upcoming split for NGM Biopharmaceuticals.
What sector and industry does NGM Biopharmaceuticals (NGM) operate in?
NGM Biopharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
NGM Biopharmaceuticals Stock (NASDAQ:NGM), Quotes and News Summary
NGM Biopharmaceuticals Stock (NASDAQ: NGM) stock price, news, charts, stock research, profile.
| Open1.130 | Close1.050 |
| Vol / Avg.803.440K / 330.315K | Mkt Cap86.851M |
| Day Range1.010 - 1.170 | 52 Wk Range1.120 - 14.400 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.500 | -0.460 | 0.0400 | ||||
| REV | 3.300M | 1.423M | -1.877M |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-05-03 | Citigroup | Samantha Semenkow | Initiates Coverage On | Buy | Announces | - | 6.00 |
| 2023-03-30 | B. Riley Securities | Mayank Mamtani | Maintains | Buy | Lowers | 8.00 | 7.00 |
| 2022-11-04 | Raymond James | Steven Seedhouse | Maintains | Outperform | Raises | 4.00 | 6.00 |
| 2022-10-18 | Cowen & Co. | Ritu Baral | Maintains | Outperform | Lowers | 32.00 | 9.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| NGM | NGM Biopharmaceuticals | -6.25% | 86.9M |
| SCYX | SCYNEXIS | -2.65% | 123.1M |
| OCUP | Ocuphire Pharma | -0.51% | 82.2M |
| RANI | Rani Therapeutics Hldgs | -6.08% | 71M |
| LBPH | Longboard Pharmaceuticals | 0.72% | 128.9M |
How do I buy NGM Biopharmaceuticals (NGM) stock?
You can purchase shares of NGM Biopharmaceuticals (NASDAQ: NGM) through any online brokerage.
Who are NGM Biopharmaceuticals's (NGM) competitors?
Other companies in NGM Biopharmaceuticals’s space includes: SCYNEXIS (NASDAQ:SCYX), Ocuphire Pharma (NASDAQ:OCUP), Rani Therapeutics Hldgs (NASDAQ:RANI), Longboard Pharmaceuticals (NASDAQ:LBPH) and Aquestive Therapeutics (NASDAQ:AQST).
What is the target price for NGM Biopharmaceuticals (NGM) stock?
The latest price target for NGM Biopharmaceuticals (NASDAQ: NGM) was reported by Citigroup on Wednesday, May 3, 2023. The analyst firm set a price target for 6.00 expecting NGM to rise to within 12 months (a possible 471.43% upside). 9 analyst firms have reported ratings in the last year.
Current Stock Price for NGM Biopharmaceuticals (NGM)?
The stock price for NGM Biopharmaceuticals (NASDAQ: NGM) is $1.05 last updated September 22, 2023 at 8:00 PM UTC.
Does NGM Biopharmaceuticals (NGM) pay a dividend?
There is no dividend information for NGM Biopharmaceuticals.
When is NGM Biopharmaceuticals (NASDAQ:NGM) reporting earnings?
NGM Biopharmaceuticals’s Q3 earnings are confirmed for Thursday, November 2, 2023.
Is NGM Biopharmaceuticals (NGM) going to split?
There is no upcoming split for NGM Biopharmaceuticals.
What sector and industry does NGM Biopharmaceuticals (NGM) operate in?
NGM Biopharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.